Top in cardiology: Vericiguat approval, air pollution and MI risk
Source/Disclosures Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS
You ve successfully added to your alerts. You will receive an email when new content is published.
Back to Healio
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Back to Healio
The FDA recently approved vericiguat to reduce heart failure hospitalization and cardiovascular mortality in adults with symptomatic chronic heart failure with reduced ejection fraction. It was the top story in cardiology last week.